DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Interlaboratory reproducibility of liquid-based equivocal cervical cytology within a randomized controlled trial framework.

Author(s): Confortini M, Bondi A, Cariaggi MP, Carozzi F, Dalla Palma P, Ghiringhello B, Minucci D, Montanari G, Parisio F, Prandi S, Schiboni ML, Ronco G

Affiliation(s): Unit of Analytical and Biomolecular Cytology, Centro per lo Studio e la Prevenzione Oncologica, Florence, Italy. m.confortini@cspo.it

Publication date & source: 2007-09, Diagn Cytopathol., 35(9):541-4.

Within a multicentre controlled trial framework, an external quality control (EQC) was scheduled to evaluate the interlaboratory reproducibility of liquid-based cytology. In particular, this EQC intended to evaluate the reproducibility of the ASCUS diagnosis.A selected set of 30 slides (4 within normal limit cases, 16 atypical squamous cells of undetermined significance; 4 low-grade squamous intraepithelial lesions and 6 high-grade squamous intraepithelial lesions) circulated among the 13 laboratories involved in the trial.Kappa values were obtained from the comparison between individual laboratory diagnoses and majority diagnoses with target diagnoses. Specific kappa values resulted moderate to high for HSIL and low to moderate for LSIL and WNL. Meanwhile, the specific kappa for ASCUS was below 0.4 in 12 of 13 participating laboratories.The lack of reproducibility for ASCUS was not a result of the introduction of this new technology but rather to the low reproducibility of the ASCUS category itself stemming from intrinsic uncertainties in the reporting criteria. (c) 2007 Wiley-Liss, Inc.

Page last updated: 2007-10-18

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017